Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absorption of sublingual fentanyl (Abstral) in head and neck cancer patients treated with curative chemo-radiotherapy
2013-003707-18Phase 4Active
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fentanyl in head and neck cancer (HNC). Primary endpoints: AUC and Clearance. Started Dec 2013; status: active.
02
Drugs
fentanyl
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on 2013-003707-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003707-18.